Human myoblasts (Cell Therapy Institute)

人肌母细胞（罗盖肌母细胞医学研究院）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman myoblasts (Cell Therapy Institute)
Drug Alias Name注射用人肌母细胞
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsDiabetes MellitusHeart Defects, CongenitalMuscular Atrophy +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesRom Build Muscle Cell Institute Of Medicine Of Wuhan Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesRom Build Muscle Cell Institute Of Medicine Of Wuhan Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes MellitusHeart Defects, CongenitalMuscular Atrophy +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A